Dashboard
1
Poor Management Efficiency with a low ROCE of 26.57%
- The company has been able to generate a Return on Capital Employed (avg) of 26.57% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 15.14% and Operating profit at 7.61% over the last 5 years
4
The company has declared negative results for the last 2 consecutive quarters
5
With ROE of 18.14%, it has a very expensive valuation with a 8.05 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.86%
0%
-28.86%
6 Months
-43.39%
0%
-43.39%
1 Year
-48.86%
0%
-48.86%
2 Years
1.99%
0%
1.99%
3 Years
19.66%
0%
19.66%
4 Years
-15.36%
0%
-15.36%
5 Years
-12.3%
0%
-12.3%
Dalian Bio-Chem Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.14%
EBIT Growth (5y)
7.61%
EBIT to Interest (avg)
54.51
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0.57
Tax Ratio
12.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.35%
ROE (avg)
21.30%
Valuation key factors
Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
8.05
EV to EBIT
37.18
EV to EBITDA
29.62
EV to Capital Employed
7.27
EV to Sales
7.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.56%
ROE (Latest)
18.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
315.90
263.60
19.84%
Operating Profit (PBDIT) excl Other Income
68.90
59.60
15.60%
Interest
9.60
9.30
3.23%
Exceptional Items
0.00
0.00
Consolidate Net Profit
54.00
12.50
332.00%
Operating Profit Margin (Excl OI)
105.30%
90.70%
1.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 19.84% vs -60.55% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 332.00% vs -92.71% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,719.30
1,260.80
36.37%
Operating Profit (PBDIT) excl Other Income
472.90
428.60
10.34%
Interest
31.30
7.60
311.84%
Exceptional Items
8.90
53.60
-83.40%
Consolidate Net Profit
307.10
397.40
-22.72%
Operating Profit Margin (Excl OI)
213.80%
284.40%
-7.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 36.37% vs 19.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -22.72% vs 21.01% in Dec 2024
About Dalian Bio-Chem Co., Ltd. 
Dalian Bio-Chem Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






